Johnson & Johnson Global Trial Finds Single Dose Covid-19 Vaccine 66% Effective
[ad_1] JOHNSON & JOHNSON HAS announced that global trials found their single dose vaccine to be 66% effective in preventing Covid-19. The results were obtained in a large trial with 44,000 volunteers that was carried out on three continents and against multiple variants of the virus. The US company said the jab was 85% effective … Read more